DOCSLIB.ORG

Common Uses & Side Effects of Medications

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Common Uses & Side Effects of Medications Common Uses & Side Effects of Medications (Emergency Department) Common Medications Common Use for Medication Side effects that MAY occur Gastrointestinal (Stomach, Intestine, Colon) Gas Famotidine (Pepcid®) -Peptic ulcers Nausea Pantoprazole (Protonix®) -GERD Dizziness -Stomach bleed Stomach pain Metoclopramide (Reglan®) Fatigue (Feeling tired) Ondansetron (Zofran®) -Nausea/vomiting Dizziness Prochlorperazine (Compazine®) Constipation Docusate sodium (Colace®) Bisacodyl (Dulcolax®) Stomach cramping Lactulose -Constipation Diarrhea Polyethylene glycol (Miralax®) Nausea Senna (Senokot®) Sodium phosphate enema (Fleet®) Aluminum hydroxide/magnesium hydroxide/simethicone Headache -Antacid (Maalox®) Stomach pain -Upset stomach Magnesium hydroxide (Milk of Magnesia®) Cramping Atropine-diphenoxylate (Lomotil®) Nausea Loperamide (Imodium®) -Diarrhea Constipation Octreotide (Sandostatin®) Stomach cramping Simethicone (Mylicon®) -Gas Most patients have no side effects Analgesics (Pain Medications) -Fever Acetaminophen (Tylenol®) -Pain relief Dizziness Nausea Gabapentin (Neurotin®) -Nerve pain relief Vomiting Pregabalin (Lyrica®) Hydromorphone (Dilaudid®) Dizziness Oxycodone (Oxycontin®) Nausea/Vomiting Oxycodone-acetaminophen (Percocet®) Constipation Methadone Confusion Morphine (MS Contin®) -Pain relief Itchiness Tramadol (Ultram®) Drowsiness Ibuprofen (Motrin®) Nausea/Vomiting Ketorolac (Toradol®) Upset Stomach Benzocaine-menthol (Cepacol®) Nausea/Vomiting Gout Allopurinol (Zyloprim®) Diarrhea Colchicine (Colcrys®) -Gout Nausea Stomach pain Common Medications Common Use for Medication Side effects that MAY occur Cardiovascular (Heart and Veins) Dizziness Bumetanide (Bumex®) Increase urination Furosemide (Lasix®) -Fluid overload Sensitivity to Hydrochlorothiazide (Microzide®) -Heart failure sunlight Metolazone (Zaroxolyn®) -High blood pressure Electrolyte Torsemide (Demadex®) imbalance Atenolol (Tenormin®) Slow heart rate Carvedilol (Coreg®) -Heart rate control Low blood pressure Labetalol (Normodyne®) -High blood pressure Dizziness Metoprolol (Lopressor®/Toprol XL®) -Heart failure Fatigue Propranolol (Inderal®) Constipation Eplerenone (Inspra®) -Heart failure Increased potassium Spironolactone (Aldactone®) -High blood pressure Breast enlargement (spironolactone) Captopril (Capoten®) -Heart failure Dizziness Lisinopril (Prinivil®) -High blood pressure Cough (Ace inhibitors) Losartan (Cozaar®) High potassium level Valsartan (Diovan®) Headache Atorvastatin (Lipitor®) -Lower cholesterol Muscle pain Pravastatin (Pravachol®) -Prevent or treat heart attack or Weakness Rosuvastatin (Crestor®) stroke Diarrhea Amlodipine (Norvasc®) Headache Diltiazem (Cardizem®) -High blood pressure Lightheadedness Nicardipine (Cardene®) -Heart rate control Dizziness Nifedipine XL (Procardia®) Verapamil (Calan®) Headache -High blood pressure Hydralazine (Apresoline®) Dizziness -Heart failure IV- irritation at injection site Neurologic/Psychiatric (Brain Medications) Alprazolam (Xanax®) -Anxiety Dizziness Chlordiazepoxide (Librium®) -Seizures Drowsiness Clonazepam (Klonopin®) -Muscle spasms Diazepam (Valium®) -Alcohol withdrawal Lorazepam (Ativan®) Carbamazepine (Tegretol®) Dizziness -Prevent and/or treat seizures or Lamotrigine (Lamictal®) Drowsiness -Help improve mood Levetiracetam (Keppra®) Rash (carbamazepine, valproic acid, Phenytoin (Dilantin®) lamotrigine) Valproic acid (Depakote®) Citalopram (Celexa®) -Depression and anxiety Headache Escitalopram (Lexapro®) Increased appetite Mirtazapine (Remeron®) Drowsiness Sertraline (Zoloft®) Nausea Haloperidol (Haldol®) -Bipolar disorder Drowsiness Olanzapine (Zyprexa®) -Schizophrenia High blood sugar Quetiapine (Seroquel®) -Anxiety Weight gain Risperidone (Risperdal®) Baclofen (Lioresal®, Gablofen®) -Muscle spasms Dry mouth Cyclobenzaprine (Flexeril®) Drowsiness Common Medications Common Use for Medication Side effects that MAY occur Antihistamine (Allergy) Diphenhydramine (Benadryl®) Sleepiness -Itchiness Hydroxyzine (Atarax®) Dizziness Pulmonary (Lungs) -Asthma Shakiness Albuterol (Proair®, Proventil®, Ventolin®) -COPD Increased heart rate Ipratropium (Atrovent®) -Shortness of breath Headache -Asthma Budesonide-formoterol (Symbicort®) Headache, oral thrush -COPD Prostate Finasteride (Proscar®) Dizziness -Enlarged prostate Tamsulosin (Flomax®) Headache Electrolytes and supplements Calcium gluconate Magnesium Oxide Diarrhea (magnesium) Magnesium Sulfate -Low electrolyte levels Upset Stomach Potassium Chloride IV- irritation at injection site Sodium Bicarbonate Calcium Carbonate Folic acid -Supplements Constipation (calcium only) Multivitamin Thiamine Cholecalciferol - Low Vitamin D levels Most people do not have side effects Ergocalciferol Vaccines Hepatitis B Vaccine (Recombivax®) -Exposure to Hepatitis B Rabies Vaccine (RabAvert®) -Exposure to Rabies Redness Pain to Injection Site Tetanus Vaccine (Adacel®) -Exposure to Tetanus Imaging Agents Diatrizoate (Gastrografin®) -Contrast Dye Allergic Reaction (rare) This information is brief and general. It should not be the only source of your information on this health care topic. It is not to be used or relied on for diagnosis or treatment. It does not take the place of instructions from your doctor. Talk to your health care providers before making a health care decision. Copyright NewYork-Presbyterian Hospital. 2018. All rights reserved. (Date 11.22.19) .
Load more

Recommended publications
  • PROVERA Medroxyprogesterone Acetate Tablets 2.5Mg, 5Mg, 10Mg, 100 Mg, 200 Mg Tablets
    PROVERA Medroxyprogesterone acetate tablets 2.5mg, 5mg, 10mg, 100 mg, 200 mg tablets What is in this leaflet establish a regular menstrual breast cancer or breast lumps cycle not diagnosed by your doctor This leaflet answers some common bleeding or discharge from questions about PROVERA. It does certain types of cancer including your nipples not contain all the available cancer of the breast, kidney and information. It does not take the endometrium (the lining of the miscarriage place of talking to your doctor or womb). pharmacist. cancer of the womb or ovary PROVERA, in combination with an uncontrolled high blood estrogen containing medicine, is All medicines have risks and pressure. benefits. Your doctor has weighed used to relieve symptoms of the risks of you taking PROVERA menopause in women with an intact Do not take PROVERA if you are against the benefits it is expected to uterus. This is called hormone pregnant or intend to become have for you. replacement therapy (HRT). pregnant. PROVERA is used to protect the If you have any concerns about lining of the uterus while the PROVERA may affect your taking this medicine, ask your estrogens relieve the symptoms of developing baby if you take it doctor or pharmacist. Keep this menopause. PROVERA is not during pregnancy. leaflet with your medicine. suitable as a HRT treatment in women who have undergone a Do not take PROVERA if the You may need to read it again. hysterectomy. packaging is torn or shows signs of tampering. Do not take Your doctor may have prescribed PROVERA after the expiry date What PROVERA is PROVERA for another purpose.
    [Show full text]
  • Liquid Spray Formulations for Buccal Delivery of Cannabinoids
    (19) TZZ_¥__T (11) EP 1 361 864 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 9/08 (2006.01) A61K 9/107 (2006.01) 04.12.2013 Bulletin 2013/49 A61K 36/185 (2006.01) (21) Application number: 02712063.3 (86) International application number: PCT/GB2002/000620 (22) Date of filing: 14.02.2002 (87) International publication number: WO 2002/064109 (22.08.2002 Gazette 2002/34) (54) LIQUID SPRAY FORMULATIONS FOR BUCCAL DELIVERY OF CANNABINOIDS FLÜSSIGE SPRAY FORMULIERUNGEN ZUR BUCCALEN VERABREICHUNG VON CANNABINOIDEN PREPARATIONS DE SPRAY LIQUIDE POUR L’ADMINISTRATION BUCCALE DE CANNABINOIDES (84) Designated Contracting States: (74) Representative: Schiller, Dominic Christopher et AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU al MC NL PT SE TR Harrison Goddard Foote LLP Designated Extension States: 4th Floor, Merchant Exchange RO SI 17-19 Whitworth Street West Manchester M1 5WG (GB) (30) Priority: 14.02.2001 GB 0103638 30.03.2001 US 280044 P (56) References cited: 05.04.2001 US 827158 WO-A-00/25127 WO-A-01/66089 11.05.2001 GB 0111597 WO-A-95/25504 WO-A1-02/32420 07.09.2001 GB 0121715 WO-A1-02/069993 US-A- 3 560 625 12.09.2001 US 951022 • EITAN ALHANATY; ET AL.: "Osmotic fragility of (43) Date of publication of application: liposomes as affected by antihemolytic 19.11.2003 Bulletin 2003/47 compounds" BIOCHIMICA ET BIOPHYSICA ACTA, vol. 339, no. 1, 1974, pages 146-155, (60) Divisional application: XP008008726 10180611.5 / 2 286 793 • PATRICIA S.
    [Show full text]
  • Student Members of the American Chemical Society Poster Presentation Event November 6, 2020 5:30 - 7:00 Pm Stonecipher Lecture Hall
    Student Members of the American Chemical Society Poster Presentation Event November 6, 2020 5:30 - 7:00 pm Stonecipher Lecture Hall Author: Brooke Underwood*, Courtney LaPointe, Dr. Jeffrey Boles Contact information: [email protected] Title: Liquid-liquid extraction and ultraviolet visible spectroscopy methods for distinguishing between hemp and marijuana Abstract: In December 2018, cannabis containing less than 0.3% tetrahydrocannabinol (THC), otherwise known as hemp, became legalized due to passage of the Farm Bill (1). This creates problems for law enforcement since current presumptive test kits either 1) don’t work at all or 2) work somewhat in differentiating between legal and illegal hemp crops. This problem exists because most hemp crops and hemp products contain low levels of THC and the carboxylated form, THCA. Our approach involves the advancement of an efficient, mobile, liquid-liquid extraction (LLE) that provides presumptive, qualitative forensic evidence of the chemical extract of a bud or other plant material. This research is focused on developing a kit that functions in a similar manner to NIK kits, commonly used by law enforcement, where all components of the kit are contained within a bag. The current NIK kit for Marijuana provides a false positive when Hemp is placed in the bag, thus creating the need for a more reliable test (2). The evidence would later be sent to a crime lab for definitive analysis and quantitation of THC by ultraviolet-visible spectroscopy (UV-vis). This research has focused on the utilization of liquid-liquid extraction techniques and commercially available stains. The methods presented are rapid (requiring no more than five to six minutes to complete).
    [Show full text]
  • Laxatives for the Management of Constipation in People Receiving Palliative Care (Review)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UCL Discovery Laxatives for the management of constipation in people receiving palliative care (Review) Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2015, Issue 5 http://www.thecochranelibrary.com Laxatives for the management of constipation in people receiving palliative care (Review) Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 BACKGROUND .................................... 2 OBJECTIVES ..................................... 4 METHODS ...................................... 4 RESULTS....................................... 7 Figure1. ..................................... 8 Figure2. ..................................... 9 Figure3. ..................................... 10 DISCUSSION ..................................... 13 AUTHORS’CONCLUSIONS . 14 ACKNOWLEDGEMENTS . 14 REFERENCES ..................................... 15 CHARACTERISTICSOFSTUDIES . 17 DATAANDANALYSES. 26 ADDITIONALTABLES. 26 APPENDICES ..................................... 28 WHAT’SNEW..................................... 35 HISTORY....................................... 35 CONTRIBUTIONSOFAUTHORS . 36 DECLARATIONSOFINTEREST . 36 SOURCESOFSUPPORT . 36 DIFFERENCES
    [Show full text]
  • Acid Reflux and Gastroesophageal Reflux Disease in Adults (The Text Basics) Graphics
    Official reprint from UpToDate® www.uptodate.com ©2020 UpToDate, Inc. and/or its affiliates. All Rights Reserved. Print Options Print | Back English Patient education: Acid reflux and gastroesophageal reflux disease in adults (The Text Basics) Graphics Written by the doctors and editors at UpToDate What is acid reflux? Acid reflux is when the acid that is normally in your stomach backs up into the esophagus. The esophagus is the tube that carries food from your mouth to your stomach (figure 1). When acid reflux causes bothersome symptoms or damage, doctors call it "gastroesophageal reflux disease" or "GERD." What are the symptoms of acid reflux? The most common symptoms are: ● Heartburn, which is a burning feeling in the chest ● Regurgitation, which is when acid and undigested food flow back into your throat or mouth Other symptoms might include: ● Stomach or chest pain ● Trouble swallowing ● Having a raspy voice or a sore throat ● Unexplained cough ● Nausea or vomiting Is there anything I can do on my own to feel better? Yes. You might feel better if you: ● Lose weight (if you are overweight) ● Raise the head of your bed by 6 to 8 inches – You can do this by putting blocks of wood or rubber under 2 legs of the bed or a foam wedge under the mattress. ● Avoid foods that make your symptoms worse – For some people these include coffee, chocolate, alcohol, peppermint, and fatty foods. ● Stop smoking, if you smoke ● Avoid late meals – Lying down with a full stomach can make reflux worse. Try to plan meals for at least 2 to 3 hours before bedtime.
    [Show full text]
  • Gastroesophageal Reflux Disease (GERD)
    Guidelines for Clinical Care Quality Department Ambulatory GERD Gastroesophageal Reflux Disease (GERD) Guideline Team Team Leader Patient population: Adults Joel J Heidelbaugh, MD Objective: To implement a cost-effective and evidence-based strategy for the diagnosis and Family Medicine treatment of gastroesophageal reflux disease (GERD). Team Members Key Points: R Van Harrison, PhD Diagnosis Learning Health Sciences Mark A McQuillan, MD History. If classic symptoms of heartburn and acid regurgitation dominate a patient’s history, then General Medicine they can help establish the diagnosis of GERD with sufficiently high specificity, although sensitivity Timothy T Nostrant, MD remains low compared to 24-hour pH monitoring. The presence of atypical symptoms (Table 1), Gastroenterology although common, cannot sufficiently support the clinical diagnosis of GERD [B*]. Testing. No gold standard exists for the diagnosis of GERD [A*]. Although 24-hour pH monitoring Initial Release is accepted as the standard with a sensitivity of 85% and specificity of 95%, false positives and false March 2002 negatives still exist [II B*]. Endoscopy lacks sensitivity in determining pathologic reflux but can Most Recent Major Update identify complications (eg, strictures, erosive esophagitis, Barrett’s esophagus) [I A]. Barium May 2012 radiography has limited usefulness in the diagnosis of GERD and is not recommended [III B*]. Content Reviewed Therapeutic trial. An empiric trial of anti-secretory therapy can identify patients with GERD who March 2018 lack alarm or warning symptoms (Table 2) [I A*] and may be helpful in the evaluation of those with atypical manifestations of GERD, specifically non-cardiac chest pain [II B*]. Treatment Ambulatory Clinical Lifestyle modifications.
    [Show full text]
  • Vaginal Administration of Contraceptives
    Scientia Pharmaceutica Review Vaginal Administration of Contraceptives Esmat Jalalvandi 1,*, Hafez Jafari 2 , Christiani A. Amorim 3 , Denise Freitas Siqueira Petri 4 , Lei Nie 5,* and Amin Shavandi 2,* 1 School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK 2 BioMatter Unit, École Polytechnique de Bruxelles, Université Libre de Bruxelles, Avenue F.D. Roosevelt, 50-CP 165/61, 1050 Brussels, Belgium; [email protected] 3 Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium; [email protected] 4 Fundamental Chemistry Department, Institute of Chemistry, University of São Paulo, Av. Prof. Lineu Prestes 748, São Paulo 05508-000, Brazil; [email protected] 5 College of Life Sciences, Xinyang Normal University, Xinyang 464000, China * Correspondence: [email protected] (E.J.); [email protected] (L.N.); [email protected] (A.S.); Tel.: +32-2-650-3681 (A.S.) Abstract: While contraceptive drugs have enabled many people to decide when they want to have a baby, more than 100 million unintended pregnancies each year in the world may indicate the contraceptive requirement of many people has not been well addressed yet. The vagina is a well- established and practical route for the delivery of various pharmacological molecules, including contraceptives. This review aims to present an overview of different contraceptive methods focusing on the vaginal route of delivery for contraceptives, including current developments, discussing the potentials and limitations of the modern methods, designs, and how well each method performs for delivering the contraceptives and preventing pregnancy.
    [Show full text]
  • “Inactive” Ingredients in Pharmaceutical Products: Update (Subject Review)
    AMERICAN ACADEMY OF PEDIATRICS Committee on Drugs “Inactive” Ingredients in Pharmaceutical Products: Update (Subject Review) ABSTRACT. Because of an increasing number of re- bronchospasm from antiasthmatic drugs, aspartame- ports of adverse reactions associated with pharmaceutical induced headache and seizures, saccharin-induced excipients, in 1985 the Committee on Drugs issued a cross-sensitivity reactions in children with sulfon- position statement1 recommending that the Food and amide allergy, benzyl alcohol toxicity in neonates Drug Administration mandate labeling of over-the- receiving high-dose continuous infusion with pre- counter and prescription formulations to include a qual- served medications, dye-related cross-reactions in itative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reac- children with aspirin intolerance, lactose-induced di- tions continue to be reported, although some are no arrhea, and propylene glycol-induced hyperosmola- longer considered clinically significant, and other new lity and lactic acidosis. Although many other excipi- reactions have emerged. The original statement, there- ents have been implicated in causing adverse fore, has been updated and its information expanded. reactions, these are the most significant in the pedi- atric population. ABBREVIATIONS. FDA, Food and Drug Administration; MDIs, metered-dose inhalers ANTIASTHMATIC MEDICATIONS It is readily appreciated that some percentage of asthmatic children will develop a “paradoxical” Pharmaceutical products often contain agents that bronchospasm after they inhale their medication. Be- have a variety of purposes, including improvement cause many of these reactions were attributed to of the appearance, bioavailability, stability, and pal- sulfite, which had been highly publicized as a caus- atability of the product. Excipients (substances ative agent, it was often first suspected.
    [Show full text]
  • Protocol for Look-Alike and Sound-Alike Drugs
    Community Mental Health for Central Michigan PROTOCOL FOR LOOK-ALIKE AND SOUND-ALIKE DRUGS This protocol should be posted in all licensed residential group homes who contract with Community Mental Health for Central Michigan ADMINISTRATIVE GUIDELINE In an effort to improve medication safety and to meet The Joint Commission’s National Patient Safety Goal Number 3, Community Mental Health for Central Michigan (CMHCM) has identified a process to address sound-alike and look-alike drugs. The Performance Improvement Team that developed this guideline will continue to monitor new drugs on the market as they are released, review the list included with this guideline on an annual basis, and provide appropriate updates. Appropriate action to prevent errors involving the interchange of these drugs will be taken. Each CMHCM site (including direct and provider network sites) where medication is distributed or administered will post the attached lists and implement a plan for preventing drug mix-ups. This plan may consist of but not be limited to: Listing both the brand and generic names on medication records. Storing products with look-alike or sound-alike names in different locations. Employing double checks in the distribution process. Affixing “name alert” stickers to areas where look-alike or sound-alike products are stored. Changing the appearance of look-alike product names on pharmacy labels, computer screens, shelf labels and bins, and medication records by highlighting, through bold face, color, and/or tall man letters, the parts of the names that are different (e.g. hydrOXYzine, hydrALAzine). Having physicians write prescriptions using both the brand and generic names.
    [Show full text]
  • Managing Opioid-Induced Constipation
    Visual summary MODIFY PAIN RELIEF Managing opioid-induced constipation Is the current dose of opioid needed to control pain? Constipation affects many patients using opioids Could pain be relieved in other ways? to relieve pain associated with advanced cancer Non-opioid analgesics Interventional pain management or terminal disease. Constipation is often multifactorial in such patients, Could an opioid with less constipating effect be used? and opioids may be one of several causes. As well Buprenorphine Transdermal fentanyl as direct treatment of the constipation, adjusting medication regimens and treating exacerbating factors may help to provide relief from bowel transit Is a referral to other specialists needed? symptoms. Palliative care Neuro-gastroenterology Pain clinic ADDRESS EXACERBATING FACTORS DIRECTLY TREAT CONSTIPATION Drugs Non-pharmacological options 5HT3 antagonists Anticholinergics Opioids Increase fluid consumption Increase dietary fibres Antipsychotics Diuretics Iron Increase physical activity (within patients’ capabilities) Calcium supplements Calcium channel blockers Privacy and comfort during defecation Chemotherapies Complementary therapy Thalidomide Vinca alkaloids Positioning on toilet (to relax the puborectalis muscle) knees higher than hips, leaning forward Busulfan Carboplatin with elbows on knees, straightened spine Manual removal Nutritional and if the constipation is severe and refractory to other therapies metabolic issues Pharmacological management Dehydration Reduced food and fluids intake Oral laxatives Poor
    [Show full text]
  • Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone | Memorial Sloan Kettering Cancer Center
    PATIENT & CAREGIVER EDUCATION Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. Brand Names: US Alamag Plus [OTC] [DSC]; Aldroxicon I [OTC]; Aldroxicon II [OTC]; Almacone Double Strength [OTC]; Almacone [OTC] [DSC]; Alumina-Magnesia-Simethicone [OTC]; Gelusil [OTC]; Geri-Mox [OTC]; HyVee Advanced Antacid [OTC]; Maalox Advanced Maximum Strength [OTC] [DSC]; Mi-Acid Maximum Strength [OTC] [DSC]; Mi-Acid [OTC] [DSC]; Mintox Plus [OTC]; Mintox Regular Strength [OTC] [DSC]; Mylanta Classic Maximum Strength Liquid [OTC]; Mylanta Classic Regular Strength Liquid [OTC]; Rulox [OTC] Brand Names: Canada Diovol Plus; Gelusil Antacid and Anti-Gas; Magsil What is this drug used for? It is used to ease too much gas in the stomach. It is used to treat heartburn and upset stomach. Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone 1/7 It may be given to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had. If you have kidney problems. This is not a list of all drugs or health problems that interact with this drug. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this drug with all of your drugs and health problems.
    [Show full text]
  • 2021 Formulary List of Covered Prescription Drugs
    2021 Formulary List of covered prescription drugs This drug list applies to all Individual HMO products and the following Small Group HMO products: Sharp Platinum 90 Performance HMO, Sharp Platinum 90 Performance HMO AI-AN, Sharp Platinum 90 Premier HMO, Sharp Platinum 90 Premier HMO AI-AN, Sharp Gold 80 Performance HMO, Sharp Gold 80 Performance HMO AI-AN, Sharp Gold 80 Premier HMO, Sharp Gold 80 Premier HMO AI-AN, Sharp Silver 70 Performance HMO, Sharp Silver 70 Performance HMO AI-AN, Sharp Silver 70 Premier HMO, Sharp Silver 70 Premier HMO AI-AN, Sharp Silver 73 Performance HMO, Sharp Silver 73 Premier HMO, Sharp Silver 87 Performance HMO, Sharp Silver 87 Premier HMO, Sharp Silver 94 Performance HMO, Sharp Silver 94 Premier HMO, Sharp Bronze 60 Performance HMO, Sharp Bronze 60 Performance HMO AI-AN, Sharp Bronze 60 Premier HDHP HMO, Sharp Bronze 60 Premier HDHP HMO AI-AN, Sharp Minimum Coverage Performance HMO, Sharp $0 Cost Share Performance HMO AI-AN, Sharp $0 Cost Share Premier HMO AI-AN, Sharp Silver 70 Off Exchange Performance HMO, Sharp Silver 70 Off Exchange Premier HMO, Sharp Performance Platinum 90 HMO 0/15 + Child Dental, Sharp Premier Platinum 90 HMO 0/20 + Child Dental, Sharp Performance Gold 80 HMO 350 /25 + Child Dental, Sharp Premier Gold 80 HMO 250/35 + Child Dental, Sharp Performance Silver 70 HMO 2250/50 + Child Dental, Sharp Premier Silver 70 HMO 2250/55 + Child Dental, Sharp Premier Silver 70 HDHP HMO 2500/20% + Child Dental, Sharp Performance Bronze 60 HMO 6300/65 + Child Dental, Sharp Premier Bronze 60 HDHP HMO
    [Show full text]